Heather Bendall

803 total citations
14 papers, 628 citations indexed

About

Heather Bendall is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Heather Bendall has authored 14 papers receiving a total of 628 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Oncology and 4 papers in Immunology. Recurrent topics in Heather Bendall's work include Immune Cell Function and Interaction (3 papers), Cancer therapeutics and mechanisms (3 papers) and Ubiquitin and proteasome pathways (3 papers). Heather Bendall is often cited by papers focused on Immune Cell Function and Interaction (3 papers), Cancer therapeutics and mechanisms (3 papers) and Ubiquitin and proteasome pathways (3 papers). Heather Bendall collaborates with scholars based in United States, Canada and Italy. Heather Bendall's co-authors include Eugene M. Oltz, Lorenzo M. Leoni, Jack Reifert, Christina C. Niemeyer, Brandi Bailey, Jacques Corbeil, Gary Elliott, Dean W. Ballard, Cornelis Murre and Michael L. Sikes and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Immunity.

In The Last Decade

Heather Bendall

13 papers receiving 611 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Heather Bendall United States	8	244	184	182	170	161	14	628
Shruti Bhatt United States	14	261 1.1×	190 1.0×	139 0.8×	274 1.6×	118 0.7×	37	658
Luhong Sun United States	10	286 1.2×	207 1.1×	127 0.7×	213 1.3×	146 0.9×	19	564
A.M. Vénuat France	12	262 1.1×	106 0.6×	97 0.5×	148 0.9×	93 0.6×	20	526
Arjan J. van Adrichem Finland	8	172 0.7×	122 0.7×	157 0.9×	108 0.6×	121 0.8×	12	440
David S. Chervinsky United States	14	496 2.0×	54 0.3×	123 0.7×	210 1.2×	107 0.7×	28	838
Vera Magistroni Italy	13	336 1.4×	91 0.5×	44 0.2×	146 0.9×	295 1.8×	23	783
Hans G. Drexler Germany	9	180 0.7×	150 0.8×	150 0.8×	154 0.9×	92 0.6×	11	485
Jonathan A. Schumacher United States	11	137 0.6×	122 0.7×	65 0.4×	62 0.4×	75 0.5×	25	374
L Pegoraro Italy	6	328 1.3×	75 0.4×	84 0.5×	98 0.6×	116 0.7×	15	551
JW Uhr United States	6	90 0.4×	109 0.6×	181 1.0×	102 0.6×	99 0.6×	10	369

Countries citing papers authored by Heather Bendall

Since Specialization

Citations

This map shows the geographic impact of Heather Bendall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heather Bendall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heather Bendall more than expected).

Fields of papers citing papers by Heather Bendall

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heather Bendall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heather Bendall. The network helps show where Heather Bendall may publish in the future.

Co-authorship network of co-authors of Heather Bendall

This figure shows the co-authorship network connecting the top 25 collaborators of Heather Bendall. A scholar is included among the top collaborators of Heather Bendall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heather Bendall. Heather Bendall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Leoni, Lorenzo M., Brandi Bailey, Jack Reifert, et al.. (2008). Bendamustine (Treanda) Displays a Distinct Pattern of Cytotoxicity and Unique Mechanistic Features Compared with Other Alkylating Agents. Clinical Cancer Research. 14(1). 309–317. 281 indexed citations

Bendall, Heather, Christina C. Niemeyer, Jack Reifert, Brandi Bailey, & Lorenzo M. Leoni. (2005). Brief exposure to SDX-105 (Treanda™) activates potent apoptosis and cell death in lymphoma and leukemia cells. Cancer Research. 65. 786–786. 1 indexed citations

Niemeyer, Christina C., Heather Bendall, Brandi Bailey, Jack Reifert, & Lorenzo M. Leoni. (2005). Mitotic catastrophe induced in cells treated with SDX-105 (Treanda™). Cancer Research. 65. 538–538. 2 indexed citations

Leoni, Lorenzo M., Brandi Bailey, Christina C. Niemeyer, et al.. (2004). In vitro and ex vivo activity of SDX-105 (bendamustine) in drug-resistant lymphoma cells. Cancer Research. 64. 278–278. 22 indexed citations

Niemeyer, Christina C., Brandi Bailey, Jack Reifert, et al.. (2004). Induction of growth arrest and apoptosis by MNNG is associated with up-regulation of Cdk inhibitor p21 and down-regulation of cyclooxygenase-2 expression. Cancer Research. 64. 257–257. 7 indexed citations

Leoni, Lorenzo M., Christina C. Niemeyer, Heather Bendall, Jack Reifert, & Brandi Bailey. (2004). SDX-105 (Treanda™), Active in Non-Hodgkin’s Lymphoma Cells, Induces the Mitotic Catastrophe Death Pathway.. Blood. 104(11). 4593–4593.

Crain, Brian, Gary Elliott, Jack Reifert, et al.. (2004). 383 Preclinical antitumor activity of second generation analogs of SDX-101. European Journal of Cancer Supplements. 2(8). 115–115. 2 indexed citations

Leoni, Lorenzo M., Brian Crain, Brandi Bailey, et al.. (2004). Mechanism of Action and Safety of Second Generation Analogs of SDX-101 (R-Etodolac).. Blood. 104(11). 3411–3411. 3 indexed citations

Bendall, Heather, Geoffrey G. Hicks, Abudi Nashabi, et al.. (2003). The High-Mobility-Group Box Protein SSRP1/T160 Is Essential for Cell Viability in Day 3.5 Mouse Embryos. Molecular and Cellular Biology. 23(15). 5301–5307. 55 indexed citations

10.

Bendall, Heather, Michael L. Sikes, & Eugene M. Oltz. (2001). Transcription Factor NF-κB Regulates Igλ Light Chain Gene Rearrangement. The Journal of Immunology. 167(1). 264–269. 16 indexed citations

11.

Bendall, Heather, et al.. (2001). The role of E2A-PBX1 in leukemogenesis. Oncogene. 20(40). 5708–5717. 89 indexed citations

12.

Bendall, Heather, Michael L. Sikes, Dean W. Ballard, & Eugene M. Oltz. (1999). An intact NF-κB signaling pathway is required for maintenance of mature B cell subsets. Molecular Immunology. 36(3). 187–195. 56 indexed citations

13.

Bendall, Heather, et al.. (1997). Transcription Factor NF-κB Regulates Inducible Oct-2 Gene Expression in Precursor B Lymphocytes. Journal of Biological Chemistry. 272(46). 28826–28828. 30 indexed citations

14.

Scherer, David C., et al.. (1996). Corepression of RelA and c-Rel Inhibits Immunoglobulin κ Gene Transcription and Rearrangement in Precursor B Lymphocytes. Immunity. 5(6). 563–574. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact